FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AGYSAGILYSYS INC

Inspect →

AGYXYAGILYX ASA / ADR

Inspect →

AHCOAdaptHealth Corp.

Inspect →

AHGAkso Health Group

Inspect →

AHIIAmerican Heritage International Inc.

Inspect →

AHL-PDASPEN INSURANCE HOLDINGS LTD

Inspect →

AHMAAMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C

Inspect →

AHNRFATHENA GOLD CORP

Inspect →

AHRAmerican Healthcare REIT, Inc.

Inspect →

AHROAuthentic Holdings, Inc.

Inspect →

AHRTAH Realty Trust, Inc.

Inspect →

AHTASHFORD HOSPITALITY TRUST INC

Inspect →

03 / FINANCIAL CHANGES

Arcus Biosciences, Inc. RCUS

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-04 · Retrieved: 2026-11-04

Compared with the same period of the prior year, ending 2025-09-30.

Revenue3.00

USD million

Change year over year: -3.00 · -50.0%

Net income-128.00

USD million

Change year over year: +7.00

Operating cash flow-88.00

USD million

Change year over year: +9.00

Total liabilities—

USD million

No comparable prior-year value

Total assets818.00

USD million

Change year over year: -156.00

Liabilities / assets: —

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-25 · Retrieved: 2026-11-04

Compared with the same period of the prior year, ending 2024-12-31.

Revenue33.00

USD million

Change year over year: -18.00 · -35.3%

Net income-353.00

USD million

Change year over year: -70.00

Operating cash flow-482.00

USD million

Change year over year: -312.00

Total liabilities—

USD million

No comparable prior-year value

Total assets1,139.00

USD million

Change year over year: -11.00

Liabilities / assets: —

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
PCRX ↗	2025-12-31	726.41	1.0%	20.9%
PTGX ↗	2025-12-31	46.02	-282.8%	125.3%
PGEN ↗	2025-12-31	9.68	-2,588.2%	-907.0%
XNCR ↗	2025-12-31	125.58	-73.2%	-107.6%
IGC ↗	2025-03-31	1.27	-560.3%	-377.3%
AMPH ↗	2025-12-31	719.89	13.6%	21.7%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

G ↗

Genpact LTD

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

AOSL ↗

ALPHA & OMEGA SEMICONDUCTOR Ltd

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

PTGX ↗

Protagonist Therapeutics, Inc

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

SMCI ↗

Super Micro Computer, Inc.

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

WLDN ↗

Willdan Group, Inc.

Filed: 2026-11-06
Period ending: 2026-10-02

Latest standalone quarter

DEI ↗

Douglas Emmett Inc

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

ALGT ↗

Allegiant Travel CO

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

FXF ↗

Invesco CurrencyShares Swiss Franc Trust

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

FXA ↗

Invesco CurrencyShares Australian Dollar Trust

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

FXY ↗

Invesco CurrencyShares Japanese Yen Trust

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

FXC ↗

Invesco CurrencyShares Canadian Dollar Trust

Filed: 2026-11-06
Period ending: 2026-09-30

Latest standalone quarter

FXB ↗

Invesco CurrencyShares British Pound Sterling Trust

Filed: 2026-11-06
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →